Ledda Ralf Form 3 INVACARE / Ralf Ledda ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Ledda Ralf

(Last) (First) (Middle)

ONE INVACARE WAY

(Street)

ELYRIA OH 44035

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
11/17/2016

3. Issuer Name and Ticker or Trading Symbol
INVACARE CORP [ IVC ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Sen VP/GM-EUR,Mid East&Africa

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares	25,200(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	(2)	08/22/2017	Common Shares	1,500	23.71	D
Employee Stock Option (Right to Buy)	(2)	08/20/2018	Common Shares	2,100	25.79	D
Employee Stock Option (Right to Buy)	(2)	08/19/2019	Common Shares	2,100	20.48	D
Employee Stock Option (Right to Buy)	(2)	08/18/2020	Common Shares	2,300	25.24	D
Employee Stock Option (Right to Buy)	(2)	09/02/2021	Common Shares	2,100	24.45	D
Employee Stock Option (Right to Buy)	(2)	08/14/2022	Common Shares	2,200	13.37	D
Employee Stock Option (Right to Buy)	(3)	03/18/2023	Common Shares	2,200	14.49	D

Explanation of Responses:

1. Restricted stock units granted pursuant to the Invacare Corporation 2013 Equity Compensation Plan in an exempt transaction under Rule 16b-3. 1,000 of these restricted stock units vest in full on May 15, 2017 after a three-year "cliff" vesting period; 400 of these restricted stock units vested on May 15, 2016, 800 of these restricted stock units vest in 1/2 increments on May 15, 2017 and May 15, 2018; 3,000 of these restricted stock units vest in 1/3 annual increments over three years commencing on May 15, 2017; and 20,000 of these restricted stock units vest in full on November 15, 2019 after a three-year "cliff" vesting period.

2. Immediately exercisable.

3. Employee stock option (with tandem tax withholding rights) held under the Invacare Corporation 2003 Performance Plan and granted on March 18, 2013. The option becomes exercisable in four equal annual installments. The first installment became exercisable on March 31, 2014, the second installment became exercisable on March 31, 2015, the third installment became exercisable on March 31, 2016, and the fourth installment becomes exercisable on March 31, 2017.

Remarks:

	/s/ Kristofer K. Spreen as attorney-in-fact for Ralf Ledda under Power of Attorney	11/21/2016
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.